BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33218700)

  • 21. Sentinel node biopsy in melanoma: Current controversies addressed.
    Madu MF; Wouters MW; van Akkooi AC
    Eur J Surg Oncol; 2017 Mar; 43(3):517-533. PubMed ID: 27590685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of Melanoma Patients Who Did Not Proceed to Sentinel Node Biopsy After Preoperative Lymphoscintigraphy.
    Ipenburg NA; Nieweg OE; Uren RF; Thompson JF
    Ann Surg Oncol; 2017 Jan; 24(1):117-126. PubMed ID: 27480356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
    Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
    J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sentinel node biopsy and lymph node dissection in the era of new systemic therapies for malignant melanoma].
    Ulmer A; Kofler L
    Hautarzt; 2019 Nov; 70(11):864-869. PubMed ID: 31605168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel node biopsy for melanoma: a study of 241 patients.
    Chakera AH; Drzewiecki KT; Eigtved A; Juhl BR
    Melanoma Res; 2004 Dec; 14(6):521-6. PubMed ID: 15577324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.
    Lee DY; Huynh KT; Teng A; Lau BJ; Vitug S; Lee JH; Stern SL; Foshag LJ; Faries MB
    Ann Surg Oncol; 2016 Mar; 23(3):1012-8. PubMed ID: 26586498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma.
    Koskivuo I; Hernberg M; Vihinen P; Virolainen S; Talve L; Seppänen M; Vahlberg T; Jahkola T
    Br J Surg; 2011 Oct; 98(10):1400-7. PubMed ID: 21638276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of 99mTc-MIBI scintigraphy and sentinel node biopsy in the detection of occult lymph node metastases from cutaneous melanoma.
    Alonso O; Martínez M; Delgado L; Lago G; Juri C; Borges AL; Lopes de Amorim MC; de Boni D; Espasandín J; Priario J
    Eur J Dermatol; 2003; 13(5):449-54. PubMed ID: 14693488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes.
    El Sharouni MA; Scolyer RA; van Gils CH; Ch'ng S; Nieweg OE; Pennington TE; Saw RPM; Shannon K; Spillane A; Stretch J; Witkamp AJ; Sigurdsson V; Thompson JF; van Diest PJ; Lo SN
    Eur J Cancer; 2022 May; 167():123-132. PubMed ID: 35256245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desmoplastic melanoma: a 12-year experience with sentinel lymph node biopsy.
    Broer PN; Walker ME; Goldberg C; Buonocore S; Braddock DT; Lazova R; Narayan D; Ariyan S
    Eur J Surg Oncol; 2013 Jul; 39(7):681-5. PubMed ID: 23522951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of intra-nodal naevi in sentinel node biopsies for malignant melanoma.
    Smith OJ; Coelho JA; Trevatt AE; Ross GL
    Eur J Surg Oncol; 2016 Sep; 42(9):1427-31. PubMed ID: 27262872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population.
    Tsutsumida A; Furukawa H; Yamamoto Y; Horiuchi K; Yoshida T; Minakawa H; Fujii S; Murao N; Kuwahara H; Minamimoto T; Fujioka H; Sakamoto T; Honma T
    Int J Clin Oncol; 2007 Aug; 12(4):245-9. PubMed ID: 17701001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of the Regional Nodal Basin Remains Highly Prognostic in Melanoma Patients with In-Transit Disease.
    Gonzalez AB; Jakub JW; Harmsen WS; Suman VJ; Markovic SN
    J Am Coll Surg; 2016 Jul; 223(1):77-85.e1. PubMed ID: 27118347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome following sentinel node biopsy plus wide local excision versus wide local excision only for primary cutaneous melanoma: analysis of 5840 patients treated at a single institution.
    van der Ploeg AP; Haydu LE; Spillane AJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF; Scolyer RA; Thompson JF
    Ann Surg; 2014 Jul; 260(1):149-57. PubMed ID: 24633018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012.
    García Fernández A; Chabrera C; García Font M; Fraile M; Lain JM; Barco I; González C; Gónzalez S; Reñe A; Veloso E; Cassadó J; Pessarrodona A; Giménez N
    Breast; 2013 Oct; 22(5):902-7. PubMed ID: 23684000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reevaluation of the locoregional recurrence rate in melanoma patients with a positive sentinel node compared to patients with palpable nodal involvement.
    Veenstra HJ; van der Ploeg IM; Wouters MW; Kroon BB; Nieweg OE
    Ann Surg Oncol; 2010 Feb; 17(2):521-6. PubMed ID: 19898903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanoma recurrence patterns after negative sentinel lymphadenectomy.
    Zogakis TG; Essner R; Wang HJ; Turner RR; Takasumi YT; Gaffney RL; Lee JH; Morton DL
    Arch Surg; 2005 Sep; 140(9):865-71; discussion 871-2. PubMed ID: 16172295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focused Ultrasound Surveillance of Lymph Nodes Following Lymphoscintigraphy Without Sentinel Node Biopsy: A Useful and Safe Strategy in Elderly or Frail Melanoma Patients.
    Ipenburg NA; Thompson JF; Uren RF; Chung D; Nieweg OE
    Ann Surg Oncol; 2019 Sep; 26(9):2855-2863. PubMed ID: 31240588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission tomography is not useful in detecting metastasis in the sentinel lymph node in patients with primary malignant melanoma stage I and II.
    Fink AM; Holle-Robatsch S; Herzog N; Mirzaei S; Rappersberger K; Lilgenau N; Jurecka W; Steiner A
    Melanoma Res; 2004 Apr; 14(2):141-5. PubMed ID: 15057045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.